MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

Search

AdaptHealth Corp

Fechado

SetorSaúde

12.66 0.64

Visão Geral

Variação de preço das ações

24h

Atual

Mín

12.44

Máximo

12.84

Indicadores-chave

By Trading Economics

Rendimento

-124M

-102M

Vendas

26M

846M

P/E

Médio do Setor

17.527

63.808

Margem de lucro

-11.998

Funcionários

10,900

EBITDA

-147M

24M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+0.4% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

281M

1.7B

Abertura anterior

12.02

Fecho anterior

12.66

Sentimento de Notícias

By Acuity

43%

57%

99 / 348 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

AdaptHealth Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

17 de abr. de 2026, 20:26 UTC

Aquisições, Fusões, Aquisições de Empresas

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17 de abr. de 2026, 18:15 UTC

Notícias Principais

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17 de abr. de 2026, 16:49 UTC

Notícias Principais

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

17 de abr. de 2026, 16:49 UTC

Notícias Principais

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

17 de abr. de 2026, 22:58 UTC

Ganhos

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 de abr. de 2026, 21:32 UTC

Conversa de Mercado

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 de abr. de 2026, 21:22 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de abr. de 2026, 21:22 UTC

Conversa de Mercado

Moody's Downgrades Belgium to A1 -- Market Talk

17 de abr. de 2026, 20:52 UTC

Ganhos

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Ganhos
Aquisições, Fusões, Aquisições de Empresas

Tech, Media & Telecom Roundup: Market Talk

17 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

17 de abr. de 2026, 20:29 UTC

Ganhos

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17 de abr. de 2026, 20:11 UTC

Aquisições, Fusões, Aquisições de Empresas

UCB to Buy Neurona Therapeutics for Up to $1.15B

17 de abr. de 2026, 19:34 UTC

Conversa de Mercado
Ganhos
Aquisições, Fusões, Aquisições de Empresas

Global Equities Roundup: Market Talk

17 de abr. de 2026, 19:34 UTC

Conversa de Mercado
Ganhos
Aquisições, Fusões, Aquisições de Empresas

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17 de abr. de 2026, 19:31 UTC

Conversa de Mercado
Notícias Principais

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17 de abr. de 2026, 19:26 UTC

Conversa de Mercado

U.S. Natural Gas Futures Edge Up -- Market Talk

17 de abr. de 2026, 19:21 UTC

Conversa de Mercado

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17 de abr. de 2026, 19:15 UTC

Conversa de Mercado

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17 de abr. de 2026, 19:07 UTC

Conversa de Mercado

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17 de abr. de 2026, 18:57 UTC

Notícias Principais

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17 de abr. de 2026, 18:53 UTC

Aquisições, Fusões, Aquisições de Empresas

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17 de abr. de 2026, 18:53 UTC

Aquisições, Fusões, Aquisições de Empresas

UCB 2026 Rev Guidance Unchanged

17 de abr. de 2026, 18:52 UTC

Aquisições, Fusões, Aquisições de Empresas

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17 de abr. de 2026, 18:52 UTC

Aquisições, Fusões, Aquisições de Empresas

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17 de abr. de 2026, 18:14 UTC

Conversa de Mercado
Notícias Principais

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17 de abr. de 2026, 18:00 UTC

Notícias Principais

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17 de abr. de 2026, 18:00 UTC

Notícias Principais

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17 de abr. de 2026, 17:31 UTC

Conversa de Mercado
Notícias Principais

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17 de abr. de 2026, 17:26 UTC

Conversa de Mercado
Ganhos

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Comparação entre Pares

Variação de preço

AdaptHealth Corp Previsão

Preço-alvo

By TipRanks

0.4% parte superior

Previsão para 12 meses

Média 12.63 USD  0.4%

Máximo 14 USD

Mínimo 9.5 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para AdaptHealth Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

3

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

7.95 / 8.505Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Strong Bearish Evidence

Sentimento

By Acuity

99 / 348 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre AdaptHealth Corp

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
help-icon Live chat